HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 179 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92 | -99.9% | 2,416 | -21.0% | 0.00% | – |
| Q4 2021 | $122,000 | +351.9% | 3,057 | +386.0% | 0.00% | – |
| Q4 2020 | $27,000 | -22.9% | 629 | -51.7% | 0.00% | – |
| Q2 2020 | $35,000 | -64.3% | 1,302 | -76.2% | 0.00% | -100.0% |
| Q1 2020 | $98,000 | -80.9% | 5,465 | -81.1% | 0.00% | -50.0% |
| Q4 2019 | $512,000 | +196.0% | 28,896 | +186.3% | 0.00% | +100.0% |
| Q2 2019 | $173,000 | -4.4% | 10,094 | -10.2% | 0.00% | 0.0% |
| Q1 2019 | $181,000 | -77.1% | 11,246 | -74.1% | 0.00% | -66.7% |
| Q3 2018 | $789,000 | -45.6% | 43,469 | -49.5% | 0.00% | -50.0% |
| Q2 2018 | $1,451,000 | -80.8% | 86,061 | -77.7% | 0.01% | -81.8% |
| Q1 2018 | $7,572,000 | +151340.0% | 386,420 | +188397.6% | 0.03% | – |
| Q2 2015 | $5,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |